Latest Insider Transactions at Uni Qure N.V. (QURE)
This section provides a real-time view of insider transactions for Uni Qure N.V. (QURE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of uniQure N.V. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of uniQure N.V.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2023
|
Jack Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,700
+19.29%
|
-
|
|
Jun 13
2023
|
Madhavan Balachandran Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,700
+23.53%
|
-
|
|
Jun 13
2023
|
Jeremy P. Springhorn Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,700
+23.53%
|
-
|
|
Jun 13
2023
|
Jeannette Potts Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,100
+50.0%
|
-
|
|
Mar 07
2023
|
Pierre Caloz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
990
-0.87%
|
$20,790
$21.33 P/Share
|
|
Mar 07
2023
|
Alexander Edward Kuta Iii Executive VP, Operations |
SELL
Open market or private sale
|
Direct |
585
-0.64%
|
$12,285
$21.36 P/Share
|
|
Mar 07
2023
|
Christian Klemt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
986
-0.73%
|
$20,706
$21.36 P/Share
|
|
Mar 07
2023
|
Ricardo Dolmetsch President, R&D |
SELL
Open market or private sale
|
Direct |
837
-0.49%
|
$17,577
$21.04 P/Share
|
|
Mar 07
2023
|
Matthew C Kapusta CEO, Managing Director |
SELL
Open market or private sale
|
Direct |
2,521
-0.53%
|
$52,941
$21.39 P/Share
|
|
Feb 28
2023
|
Christian Klemt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,369
-1.0%
|
$27,380
$20.9 P/Share
|
|
Feb 28
2023
|
Alexander Edward Kuta Iii Executive VP, Operations |
SELL
Open market or private sale
|
Direct |
1,212
-1.31%
|
$25,452
$21.04 P/Share
|
|
Feb 28
2023
|
Matthew C Kapusta CEO, Managing Director |
SELL
Open market or private sale
|
Direct |
5,021
-1.05%
|
$100,420
$20.9 P/Share
|
|
Feb 28
2023
|
Robert Gut Director |
SELL
Open market or private sale
|
Direct |
1,431
-3.28%
|
$30,051
$21.16 P/Share
|
|
Feb 27
2023
|
Leonard E Post Director |
SELL
Open market or private sale
|
Direct |
389
-3.19%
|
$7,391
$19.73 P/Share
|
|
Feb 27
2023
|
Jeremy P. Springhorn Director |
SELL
Open market or private sale
|
Direct |
384
-1.92%
|
$7,680
$20.41 P/Share
|
|
Feb 27
2023
|
Ricardo Dolmetsch President, R&D |
SELL
Open market or private sale
|
Direct |
6,944
-3.92%
|
$131,936
$19.58 P/Share
|
|
Feb 27
2023
|
Christian Klemt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,824
-6.7%
|
$196,480
$20.1 P/Share
|
|
Feb 27
2023
|
Pierre Caloz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,365
-1.84%
|
$87,300
$20.2 P/Share
|
|
Feb 27
2023
|
Paula Soteropoulos Director |
SELL
Open market or private sale
|
Direct |
384
-2.34%
|
$7,296
$19.97 P/Share
|
|
Feb 27
2023
|
Madhavan Balachandran Director |
SELL
Open market or private sale
|
Direct |
384
-1.92%
|
$7,296
$19.99 P/Share
|
|
Feb 27
2023
|
Alexander Edward Kuta Iii Executive VP, Operations |
SELL
Open market or private sale
|
Direct |
5,514
-5.64%
|
$104,766
$19.99 P/Share
|
|
Feb 27
2023
|
David D. Meek Director |
SELL
Open market or private sale
|
Direct |
389
-2.36%
|
$7,391
$19.71 P/Share
|
|
Feb 27
2023
|
Jack Kaye Director |
SELL
Open market or private sale
|
Direct |
384
-1.37%
|
$7,296
$19.99 P/Share
|
|
Feb 27
2023
|
Rachelle Suzanne Jacques Director |
SELL
Open market or private sale
|
Direct |
384
-3.62%
|
$7,680
$20.02 P/Share
|
|
Feb 27
2023
|
Matthew C Kapusta CEO, Managing Director |
SELL
Open market or private sale
|
Direct |
19,526
-1.97%
|
$390,520
$20.05 P/Share
|
|
Feb 27
2023
|
Robert Gut Director |
SELL
Open market or private sale
|
Direct |
537
-1.22%
|
$10,203
$19.79 P/Share
|
|
Feb 23
2023
|
Christian Klemt Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,400
+20.32%
|
-
|
|
Feb 23
2023
|
Matthew C Kapusta CEO, Managing Director |
BUY
Grant, award, or other acquisition
|
Direct |
121,500
+19.68%
|
-
|
|
Feb 23
2023
|
Pierre Caloz Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,700
+28.27%
|
-
|
|
Feb 23
2023
|
Ricardo Dolmetsch President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
46,700
+20.87%
|
-
|
|
Feb 20
2023
|
Pierre Caloz Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,920
+3.91%
|
-
|
|
Feb 20
2023
|
Ricardo Dolmetsch President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
2,920
+2.19%
|
-
|
|
Feb 20
2023
|
Christian Klemt Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,040
+1.83%
|
-
|
|
Feb 20
2023
|
Matthew C Kapusta CEO, Managing Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,830
+1.53%
|
-
|
|
Feb 20
2023
|
Alexander Edward Kuta Iii Executive VP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
2,040
+2.05%
|
-
|
|
Jan 18
2023
|
Paula Soteropoulos Director |
SELL
Open market or private sale
|
Direct |
6,000
-26.81%
|
$132,000
$22.59 P/Share
|
|
Jan 18
2023
|
Paula Soteropoulos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+21.14%
|
$30,000
$5.37 P/Share
|
|
Dec 14
2022
|
Paula Soteropoulos Director |
SELL
Open market or private sale
|
Direct |
3,800
-18.83%
|
$87,400
$23.43 P/Share
|
|
Dec 14
2022
|
Paula Soteropoulos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,800
+15.85%
|
-
|
|
Dec 13
2022
|
Paula Soteropoulos Director |
SELL
Open market or private sale
|
Direct |
3,000
-15.48%
|
$69,000
$23.45 P/Share
|
|
Dec 13
2022
|
Paula Soteropoulos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+13.4%
|
$15,000
$5.37 P/Share
|
|
Dec 09
2022
|
Pierre Caloz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,941
-4.1%
|
$64,702
$22.22 P/Share
|
|
Dec 09
2022
|
Ricardo Dolmetsch President, R&D |
SELL
Open market or private sale
|
Direct |
2,219
-1.71%
|
$48,818
$22.3 P/Share
|
|
Dec 09
2022
|
Matthew C Kapusta CEO, Managing Director |
SELL
Open market or private sale
|
Direct |
6,648
-1.77%
|
$146,256
$22.44 P/Share
|
|
Dec 09
2022
|
Alexander Edward Kuta Iii Executive VP, Operations |
SELL
Open market or private sale
|
Direct |
2,338
-2.39%
|
$51,436
$22.34 P/Share
|
|
Dec 09
2022
|
Christian Klemt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,608
-2.38%
|
$57,376
$22.35 P/Share
|
|
Nov 29
2022
|
Paula Soteropoulos Director |
SELL
Open market or private sale
|
Direct |
6,200
-27.46%
|
$155,000
$25.38 P/Share
|
|
Nov 29
2022
|
Paula Soteropoulos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,200
+21.54%
|
-
|
|
Nov 22
2022
|
Ricardo Dolmetsch President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
7,300
+5.33%
|
-
|
|
Nov 22
2022
|
Matthew C Kapusta CEO, Managing Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,575
+3.74%
|
-
|